RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vanessa Rivera-Amill to Serologic Tests

Back to Details
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Serologic Tests.
Vanessa Rivera-Amill
Connection Strength
0.252
Serologic Tests
  1. Munoz-Jordan J, Cardona J, Beltr?n M, Col?n C, Schiffer J, Stewart-Clark E, Zellner B, Semenova V, Li Y, Jia LT, Maniatis P, Pawloski L, Adams L, Paz-Bailey G, Rivera-Amill V, Medina F. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):375-377.
    View in: PubMed
    Score: 0.202
  2. Medina FA, Vila F, Premkumar L, Lorenzi O, Paz-Bailey G, Alvarado LI, Rivera-Amill V, de Silva A, Waterman S, Mu?oz-Jord?n J. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission. Am J Trop Med Hyg. 2021 12 20; 106(2):585-592.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support